TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).

P Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.